Abnormal movement in US stocks | AI medical concept stocks are strong Illumina (ILMN.US) soars more than 18%

According to the Zhitong Financial APP, on Friday, AI medical concept stocks performed strongly, with Illumina (ILMN.US) surging over 18% after its earnings report, CRISPR Therapeutics (CRSP.US) rising over 6%, Hims & Hers Health (HIMS.US) increasing over 5%, Tempus AI (TEM.US), and Teladoc Health (TDOC.US) up over 2%. In terms of news, Illumina exceeded revenue and profit expectations in the third quarter, with adjusted earnings per share (EPS) of $1.34, higher than market expectations of $1.19 (an increase of 18% year-on-year from $1.14). Revenue was $1.084 billion, flat year-on-year but still higher than market expectations of $1.065 billion, thanks to accelerated growth in the clinical business segment, offsetting restrictions in the China market and broader market challenges.